Skip to content
POCN Logo POCN Logo POCN Logo
  • Centers of Excellence
    • Alzheimer’s Disease
    • Atopic Dermatitis
    • Bipolar I Disorder
    • Chronic Kidney Disease
    • Heart Failure
    • Hepatitis C
    • IBS-C
    • Iron Deficiency
    • Major Depressive Disorder
    • MASH
    • Multiple Myeloma
    • NSCLC
    • Obesity
    • Overactive Bladder
    • Plaque Psoriasis
    • Psoriatic Arthritis
    • Rare Disease
    • Schizophrenia
    • Tardive Dyskinesia
    • Type 2 Diabetes
  • News
  • POCN+ ™
  • Mentor Program
  • America’s Top NP/PA
  • Be a Leader
  • Login
  1. :
  2. Home
  3. Tardive Dyskinesia
  4. Study Reveals Comorbidities and Outcomes in Psychiatric Inpatients With Tardive Dyskinesia: Implications for Severe Illness and Healthcare Costs

Study Reveals Comorbidities and Outcomes in Psychiatric Inpatients With Tardive Dyskinesia: Implications for Severe Illness and Healthcare Costs

Researchers of a study analyzed comorbidities and outcomes in psychiatric inpatients with tardive dyskinesia (TD).

Read More> https://tardivedyskinesia.pocn.com/patient-management/study-reveals-comorbidities-and-outcomes-in-psychiatric-inpatients-with-tardive-dyskinesia-implications-for-severe-illness-and-healthcare-costs/

POCNnews2023-10-10T18:01:53+00:00October 2nd, 2023|Tardive Dyskinesia|Comments Off on Study Reveals Comorbidities and Outcomes in Psychiatric Inpatients With Tardive Dyskinesia: Implications for Severe Illness and Healthcare Costs

Share This Story, Choose Your Platform!

FacebookXLinkedInEmail

Related Posts

Managing Tardive Dyskinesia: Risk Factors, Early Detection, and Effective Treatments

March 12th, 2025

Deep Brain Stimulation and Treatment for Severe Tardive Dyskinesia

March 12th, 2025

Exploring the Link Between Non-DRBD Medications and Tardive Dyskinesia

March 12th, 2025

Impact of Tardive Dyskinesia on Caregivers: Strain on Well-Being, Work, and Daily Life

March 12th, 2025

Study Highlights Major Impact of Tardive Dyskinesia, Urges Greater Awareness and Early Intervention

October 7th, 2024

Experts Discuss Managing Co-Occurring Drug-Induced Parkinsonism and Tardive Dyskinesia

October 7th, 2024

Understanding the Differences Between Tardive Dyskinesia and Other Movement Disorders

October 7th, 2024

Tardive Dyskinesia Impact Scale Offers Comprehensive Patient Perspective on Physical and Socioemotional Impacts

October 7th, 2024

  • Privacy Policy

  • Your Privacy Choices

  • Terms of Use

  • Contact

  • Ambassador Program

© POCN – an IQVIA Business. All Rights Reserved.

Page load link
Go to Top